Cargando…
Plasmodium falciparum resistance to artemisinin-based combination therapies: A sword of Damocles in the path toward malaria elimination
The use of artemisinin-based combination therapies (ACTs), which combine an artemisinin derivative with a partner drug, in the treatment of uncomplicated malaria has largely been responsible for the significant reduction in malaria-related mortality in tropical and subtropical regions. ACTs have als...
Autores principales: | Ouji, Manel, Augereau, Jean-Michel, Paloque, Lucie, Benoit-Vical, Françoise |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
EDP Sciences
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909375/ https://www.ncbi.nlm.nih.gov/pubmed/29676250 http://dx.doi.org/10.1051/parasite/2018021 |
Ejemplares similares
-
Plasmodium falciparum: multifaceted resistance to artemisinins
por: Paloque, Lucie, et al.
Publicado: (2016) -
Epidrugs as Promising Tools to Eliminate Plasmodium falciparum Artemisinin-Resistant and Quiescent Parasites
por: Reyser, Thibaud, et al.
Publicado: (2023) -
Mutation in the Plasmodium falciparum BTB/POZ Domain of K13 Protein Confers Artemisinin Resistance
por: Paloque, Lucie, et al.
Publicado: (2022) -
Hybrid Gold(I) NHC-Artemether Complexes to Target Falciparum Malaria Parasites
por: Ouji, Manel, et al.
Publicado: (2020) -
The sword of Damocles for the splenectomised: death by OPSI
por: Blumentrath, Christian Georg, et al.
Publicado: (2016)